Results 211 to 220 of about 269,841 (233)

Final overall survival and safety analyses of the phase III PSMAfore trial of [<sup>177</sup>Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer. [PDF]

open access: yesAnn Oncol
Fizazi K   +18 more
europepmc   +1 more source

Patients' anxieties and fears: a comparison between transrectal prostate biopsy and prostate MRI. [PDF]

open access: yesTransl Androl Urol
Steinkohl F   +6 more
europepmc   +1 more source

Early reduction in gut microbiota diversity in critically ill patients is associated with mortality. [PDF]

open access: yesAnn Intensive Care
Wozniak H   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy